TA
IDNA icon

TCG Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

TCG Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,374
Closed -$280K – 54
2020
Q2 		$280K Buy
+7,374
New +$249K 0.16% 109

Other funds holding IDNA

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
RCS
Retirement Capital Strategies San Jose, California $288M AUM 17.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TCG Advisors's IDNA Position: Q3 2020 in Review

TCG Advisors sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2020, closing a stake of 7,374 shares — an estimated $280K sold.

TCG Advisors first reported a position in IDNA in Q2 2020 and held it in 1 quarter. The position peaked at $280K in Q2 2020. 48 funds tracked by Wall St. Rank hold IDNA as of Q3 2020.

  • TCG Advisors reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2020 after selling out during the quarter.
  • TCG Advisors sold 7,374 iShares Genomics Immunology and Healthcare ETF shares in Q3 2020, an estimated $280K.
  • TCG Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 1 quarter.
  • TCG Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $280K in Q2 2020.
  • 48 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2020.

Based on TCG Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.